“Deferasirox on COVID-19: safety and efficacy of iron-chelating therapy. A multicentric, randomized, triple blinded study” (2022) Principles and Practice of Clinical Research, 7(4), pp. 38–46. doi:10.21801/ppcrj.2021.74.5.